CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-31 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-12-31 | LAWLIS V BRYAN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-12-23 | Wahlstrom Mats Director | Other disposition | −221,538 | 0 | ||
| 2014-12-23 | Wahlstrom Mats Director | Other acquisition | +114,639 | 709,482 | ||
| 2014-12-23 | Lanfear Dennis M See Remarks | Gift | −20,000 | 1,341,921 | ||
| 2014-11-12 | KKR Biosimilar L.P. 10% owner | Conversion | +2,499,499 | 2,499,499 | ||
| 2014-11-12 | KKR Biosimilar L.P. 10% owner | Conversion · Series C Preferred Stock | −2,499,499 | 0 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion | +194,889 | 194,889 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion | +26,649 | 221,538 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion | +514,893 | 514,893 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion | +79,950 | 594,843 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion | +43,011 | 43,011 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion | +10,572 | 53,583 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion · Series B Preferred Stock | −194,889 | 0 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion · Series B Preferred Stock | −26,649 | 0 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion · Series B Preferred Stock | −514,893 | 0 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion · Series C Preferred Stock | −79,950 | 0 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion · Series C Preferred Stock | −43,011 | 0 | ||
| 2014-11-12 | Wahlstrom Mats Director | Conversion · Series C Preferred Stock | −10,572 | 0 | ||
| 2014-11-12 | HEALY JAMES Director | Conversion | +47 | 47 |
Page 35 of 39 · 768 trades